Embryoâfetal safety evaluation of ondansetron in rats
Sign Up to like & getrecommendations! Published in 2023 at "Birth Defects Research"
DOI: 10.1002/bdr2.2154
Abstract: Ondansetron is a 5HT3 receptor antagonist, used to mitigate the effects of nausea and vomiting after chemotherapy or surgery. Since nausea and vomiting are common experiences during the first trimester of pregnancy, this antiemetic has… read more here.
Keywords: safety evaluation; ondansetron rats; embryo fetal; evaluation ondansetron ... See more keywords